Recruitment, Inclusion, and Diversity in Clinical Trials

Bernadette Boden-Albala; Salina P. Waddy; Noa Appleton; Heather Kuczynski; Emily Nangle; Nina S. Parikh

doi:10.1002/9781119374855.ch24

Recruitment, Inclusion, and Diversity in Clinical Trials

Bernadette Boden-Albala, Salina P. Waddy, Noa Appleton, Heather Kuczynski, Emily Nangle, Nina S. Parikh

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

In this chapter, we discuss the importance of diversity and the inclusion of women and racial/ethnic minority groups in clinical research as a foundation for addressing health disparities. First, we provide a brief background on the scientific and ethical significance of diversity and inclusion in clinical research. Next, we discuss barriers to recruiting representative study populations, including: (i) optimizing the screening pool, (ii) converting eligible participants to enrolled research subjects, and (iii) retaining subjects in a study. We specifically examine patient/community-, investigator-, and structural/institutional-level barriers. Finally, we summarize various best practices for enhancing inclusion of under-represented groups in clinical research, as well as future directions and research needs.

Original language	English (US)
Title of host publication	The Science of Health Disparities Research
Publisher	Wiley
Pages	413-428
Number of pages	16
ISBN (Electronic)	9781119374855
ISBN (Print)	9781119374817
DOIs	https://doi.org/10.1002/9781119374855.ch24
State	Published - Jan 1 2021

Keywords

clinical trials
ethnic minorities
inclusion standards
minority recruitment
racial ethnic group

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1002/9781119374855.ch24

Cite this

@inbook{d24cb09ee24b497eab57934df1e6d4d5,

title = "Recruitment, Inclusion, and Diversity in Clinical Trials",

abstract = "In this chapter, we discuss the importance of diversity and the inclusion of women and racial/ethnic minority groups in clinical research as a foundation for addressing health disparities. First, we provide a brief background on the scientific and ethical significance of diversity and inclusion in clinical research. Next, we discuss barriers to recruiting representative study populations, including: (i) optimizing the screening pool, (ii) converting eligible participants to enrolled research subjects, and (iii) retaining subjects in a study. We specifically examine patient/community-, investigator-, and structural/institutional-level barriers. Finally, we summarize various best practices for enhancing inclusion of under-represented groups in clinical research, as well as future directions and research needs.",

keywords = "clinical trials, ethnic minorities, inclusion standards, minority recruitment, racial ethnic group",

author = "Bernadette Boden-Albala and Waddy, {Salina P.} and Noa Appleton and Heather Kuczynski and Emily Nangle and Parikh, {Nina S.}",

note = "Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons, Inc.",

year = "2021",

month = jan,

day = "1",

doi = "10.1002/9781119374855.ch24",

language = "English (US)",

isbn = "9781119374817",

pages = "413--428",

booktitle = "The Science of Health Disparities Research",

publisher = "Wiley",

}

TY - CHAP

T1 - Recruitment, Inclusion, and Diversity in Clinical Trials

AU - Boden-Albala, Bernadette

AU - Waddy, Salina P.

AU - Appleton, Noa

AU - Kuczynski, Heather

AU - Nangle, Emily

AU - Parikh, Nina S.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - In this chapter, we discuss the importance of diversity and the inclusion of women and racial/ethnic minority groups in clinical research as a foundation for addressing health disparities. First, we provide a brief background on the scientific and ethical significance of diversity and inclusion in clinical research. Next, we discuss barriers to recruiting representative study populations, including: (i) optimizing the screening pool, (ii) converting eligible participants to enrolled research subjects, and (iii) retaining subjects in a study. We specifically examine patient/community-, investigator-, and structural/institutional-level barriers. Finally, we summarize various best practices for enhancing inclusion of under-represented groups in clinical research, as well as future directions and research needs.

AB - In this chapter, we discuss the importance of diversity and the inclusion of women and racial/ethnic minority groups in clinical research as a foundation for addressing health disparities. First, we provide a brief background on the scientific and ethical significance of diversity and inclusion in clinical research. Next, we discuss barriers to recruiting representative study populations, including: (i) optimizing the screening pool, (ii) converting eligible participants to enrolled research subjects, and (iii) retaining subjects in a study. We specifically examine patient/community-, investigator-, and structural/institutional-level barriers. Finally, we summarize various best practices for enhancing inclusion of under-represented groups in clinical research, as well as future directions and research needs.

KW - clinical trials

KW - ethnic minorities

KW - inclusion standards

KW - minority recruitment

KW - racial ethnic group

UR - http://www.scopus.com/inward/record.url?scp=85131974512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131974512&partnerID=8YFLogxK

U2 - 10.1002/9781119374855.ch24

DO - 10.1002/9781119374855.ch24

M3 - Chapter

AN - SCOPUS:85131974512

SN - 9781119374817

SP - 413

EP - 428

BT - The Science of Health Disparities Research

PB - Wiley

ER -

Recruitment, Inclusion, and Diversity in Clinical Trials

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this